Where Will Regeneron Pharmaceuticals Be in 1 Year?

Regeneron Pharmaceuticals (REGN 0.39%) is a growing biotech company that generates a ton of free cash flow. Over the years, it has obtained approval or authorization for 12 medicines. Its strong in-house development has made it one of the larger healthcare stocks in the world, with a market capitalization in excess of $90 billion. In five years, shares of Regeneron have risen close to 130%, soundly outperforming the S&P 500 index and its more modest 87% gains. The business has been a popular investment opti ...